600812 华北制药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额883,1831,024,2671,004,3911,050,242752,147
投资活动产生之现金流量净额(327,425)(881,755)(528,465)(779,264)(843,575)
筹资活动产生之现金流量净额356,143(704,143)(4,478,604)314,5763,433,408
汇率变动对现金及现金等价物的影响8,66312,0688,438(3,135)(11,144)
现金及现金等价物净增加/(减少)920,563(549,563)(3,994,240)582,4203,330,836
期初现金及现金等价物余额505,0051,054,5685,048,8084,466,3881,135,553
期末现金及现金等价物余额1,425,568505,0051,054,5685,048,8084,466,388